This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Aveo Pharmaceuticals, Inc.. Active years: 2013-2014.
Company Filing History:
Years Active: 2013-2014
Title: James Gifford: Innovator in Cancer Treatment
Introduction
James Gifford is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of cancer treatment through his innovative work on monoclonal antibodies. With a total of 2 patents, Gifford's research focuses on targeting specific receptors involved in cancer progression.
Latest Patents
Gifford's latest patents include the development of anti-RON antibodies. These monoclonal antibodies bind to and inhibit the activation of human RON (Recepteur d'Origine Nantais). The implications of this research are profound, as these antibodies can be utilized to treat certain forms of cancer associated with the activation of RON.
Career Highlights
James Gifford is currently employed at Aveo Pharmaceuticals, Inc., where he continues to advance his research in oncology. His work is pivotal in the ongoing fight against cancer, providing new avenues for treatment and improving patient outcomes.
Collaborations
Gifford collaborates with talented individuals such as Qing Liu and Kristan Meetze, contributing to a dynamic research environment focused on innovative cancer therapies.
Conclusion
James Gifford's contributions to cancer treatment through his patents and work at Aveo Pharmaceuticals, Inc. highlight his role as a key innovator in the field. His research on anti-RON antibodies represents a significant advancement in the fight against cancer.